S K Tyring

1.1k total citations
37 papers, 796 citations indexed

About

S K Tyring is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, S K Tyring has authored 37 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 8 papers in Dermatology and 7 papers in Oncology. Recurrent topics in S K Tyring's work include Cervical Cancer and HPV Research (10 papers), Herpesvirus Infections and Treatments (10 papers) and Virus-based gene therapy research (5 papers). S K Tyring is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Herpesvirus Infections and Treatments (10 papers) and Virus-based gene therapy research (5 papers). S K Tyring collaborates with scholars based in United States, Colombia and United Kingdom. S K Tyring's co-authors include Jashin J. Wu, Sylvia Hsu, Katie R. Pang, Thomas Ruzicka, Gabriele Arendt, Andrea Tannapfel, Raimund Erbel, Ulrich R. Hengge, Miriam M. Brysk and Stefan D. Trocmé and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

S K Tyring

37 papers receiving 756 citations

Peers

S K Tyring

EPIDE

IMMUN

PARAS

ONCOL

Lyubomir Dourmishev Bulgaria

Nicola di Meo Italy

Friedrich Breier Austria

Assen L. Dourmishev Bulgaria

Alice Y. Matoba United States

Giovanni Almanzar Germany

Mir A. Ali United States

Paul M. Fitch United Kingdom

C. Löliger Germany

Mary Wu Chang United States

Lyubomir Dourmishev Bulgaria

S K Tyring

464 ×1.7

EPIDE

223 ×1.5

113 ×0.8

IMMUN

47 ×0.4

PARAS

272 ×2.3

ONCOL

Citations per year, relative to S K Tyring S K Tyring (= 1×) peers Lyubomir Dourmishev

Countries citing papers authored by S K Tyring

Since Specialization

Citations

This map shows the geographic impact of S K Tyring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S K Tyring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S K Tyring more than expected).

Fields of papers citing papers by S K Tyring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S K Tyring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S K Tyring. The network helps show where S K Tyring may publish in the future.

Co-authorship network of co-authors of S K Tyring

This figure shows the co-authorship network connecting the top 25 collaborators of S K Tyring. A scholar is included among the top collaborators of S K Tyring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S K Tyring. S K Tyring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Marilyn T., Megan H. Noe, Daniel B. Shin, et al.. (2019). 538 The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo. Journal of Investigative Dermatology. 139(5). S93–S93. 1 indexed citations

Leonardi, C., Kim Papp, Bruce Strober, et al.. (2019). Long‐term safety of adalimumab in adult patients with plaque psoriasis. British Journal of Dermatology. 180(1). e13–e13. 1 indexed citations

Rady, Peter L., et al.. (2012). Acquired Epidermodysplasia Verruciformis in a Child with Atopic Dermatitis. Pediatric Dermatology. 31(3). 400–402. 9 indexed citations

Pan, Jianbin, Jianmin Chen, Joyce Poast, et al.. (2006). Detection of very early antibody to native HIV antigens by HIV neutralization and live-cell immunofluorescence assays. Antiviral Research. 70(2). 21–27. 1 indexed citations

Wu, Jashin J., et al.. (2005). Thalidomide: dermatological indications, mechanisms of action and side-effects. British Journal of Dermatology. 153(2). 254–273. 139 indexed citations

Bernstein, David I., F. Y. Aoki, S K Tyring, et al.. (2005). Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine. Clinical Infectious Diseases. 40(9). 1271–1281. 62 indexed citations

Wu, Jashin J., et al.. (2004). Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. Antiviral Research. 64(2). 79–83. 61 indexed citations

Hengge, Ulrich R., Andrea Tannapfel, S K Tyring, et al.. (2003). Lyme borreliosis. The Lancet Infectious Diseases. 3(8). 489–500. 124 indexed citations

Sierra‐Torres, Carlos H., S K Tyring, & William W. Au. (2003). Risk contribution of sexual behavior and cigarette smoking to cervical neoplasia. International Journal of Gynecological Cancer. 13(5). 617–625. 8 indexed citations

10.

Langley, Paul C., S K Tyring, & Michael Smith. (1999). The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.. PubMed. 5(1). 69–77. 25 indexed citations

11.

Arany, István, Miriam M. Brysk, Concepcion D. Arrastia, & S K Tyring. (1999). Cidofovir regulates expression of various cyclins in human papillomavirus-infected keratinocytes. Journal of Investigative Dermatology. 112(4). 604. 2 indexed citations

12.

Lei, Guanghua, Henry Brysk, István Arany, et al.. (1999). Characterization of zinc‐α2‐glycoprotein as a cell adhesion molecule that inhibits the proliferation of an oral tumor cell line. Journal of Cellular Biochemistry. 75(1). 160–169. 2 indexed citations

13.

Weiss, Helen A., et al.. (1997). Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial.. American Journal of Ophthalmology. 123(5). 723–723. 20 indexed citations

14.

Tyring, S K, et al.. (1996). Interferons. An Overview of Their Pharmacology.. Clinical Immunotherapeutics. 5. 22–30. 5 indexed citations

15.

Memar, Omeed, et al.. (1995). Cutaneous manifestations of HIV-1 infection. Journal of the American Podiatric Medical Association. 85(7). 362–374. 9 indexed citations

16.

Bonnez, William, et al.. (1993). Evolution of the antibody response to human papillomavirus type 11 (HPV‐11) in patients with condyloma acuminatum according to treatment response. Journal of Medical Virology. 39(4). 340–344. 9 indexed citations

17.

Schlesinger, Ilana, Richard Wagner, & S K Tyring. (1993). Potential and limitations of topical sunscreens. 8(1). 19–32. 2 indexed citations

18.

Evers, B. Mark, Peter L. Rady, S K Tyring, et al.. (1992). Amplification of the HER-2/neu protooncogene in human endocrine tumors.. PubMed. 112(2). 211–7; discussion 217. 26 indexed citations

19.

Shepherd, Mary, S. Raimer, S K Tyring, & Edgar B. Smith. (1991). Treatment of necrolytic migratory erythema in glucagonoma syndrome. Journal of the American Academy of Dermatology. 25(5). 925–928. 31 indexed citations

20.

Cauda, Roberto, et al.. (1987). Diminished Interferon Gamma Production May Be the Earliest Indicator of Infection with the Human Immunodeficiency Virus. Viral Immunology. 1(4). 247–258. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact